İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - haloperidol - solution for injection - 5 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - haloperidol decanoate, quantity: 70.52 mg/ml (equivalent: haloperidol, qty 50 mg/ml) - injection, solution - excipient ingredients: benzyl alcohol; sesame oil - haldol decanoate is indicated for the maintenance therapy of psychoses in adults; particularly for patients requiring prolonged parenteral neuroleptic therapy

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - haloperidol - solution for injection - 5mg/1ml

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - haloperidol decanoate, quantity: 70.52 mg/ml (equivalent: haloperidol, qty 50 mg/ml) - injection, solution - excipient ingredients: sesame oil; benzyl alcohol - haldol decanoate is indicated for the maintenance therapy of psychoses in adults; particularly for patients requiring prolonged parenteral neuroleptic therapy.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; (s)-lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia

ABD - İngilizce - NLM (National Library of Medicine)

patriot pharmaceuticals llc - haloperidol decanoate (unii: ac20pj4101) (haloperidol - unii:j6292f8l3d) - haloperidol 50 mg in 1 ml - haloperidol decanoate 50 and haloperidol decanoate 100 are indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy. since the pharmacologic and clinical actions of haloperidol decanoate 50 and haloperidol decanoate 100 are attributed to haloperidol as the active medication, contraindications, warnings, and additional information are those of haloperidol, modified only to reflect the prolonged action. haloperidol is contraindicated in patients with: - severe toxic central nervous system depression or comatose states from any cause. - hypersensitivity to this drug – hypersensitivity reactions have included anaphylactic reaction and angioedema (see warnings, hypersensitivity reactions and adverse reactions). - parkinson's disease (see warnings, neurological adverse reactions in patients with parkinson's disease or dementia with lewy bodies). - dementia with lewy bodies (see warnings, neurological adverse reactions in patients with parkinson's disease or

Malta - İngilizce - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - haloperidol - solution for injection - haloperidol 5 mg/ml - psycholeptics

Malta - İngilizce - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - haloperidol - solution for injection - haloperidol 5 mg - psycholeptics

İsrail - İngilizce - Ministry of Health

j-c health care ltd - haloperidol as decanoate - solution for injection - haloperidol as decanoate 100 mg/ml - haloperidol - haloperidol - indicated for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients currently stabilized with oral haloperidol.

İsrail - İngilizce - Ministry of Health

unipharm trading ltd, israel - haloperidol as decanoate - solution for injection - haloperidol as decanoate 100 mg/ml - haloperidol - haloperidol - indicated for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients currently stabilized with oral haloperidol..